These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 23204064)

  • 1. Co-trimoxazole for idiopathic pulmonary fibrosis: time for TIPAC-2?
    Mujakperuo H; McGrath EE; Thickett DR
    Thorax; 2013 Feb; 68(2):123-4. PubMed ID: 23204064
    [No Abstract]   [Full Text] [Related]  

  • 2. Author's response: co-trimoxazole treatment in idiopathic pulmonary fibrosis.
    Shulgina L; Cahn AP; Chilvers ER; Parfrey H; Clark AB; Wilson EC; Twentyman OP; Davison AG; Curtin JJ; Crawford MB; Wilson AM
    Thorax; 2013 Sep; 68(9):884-5. PubMed ID: 23935173
    [No Abstract]   [Full Text] [Related]  

  • 3. Idiopathic pulmonary fibrosis or not: antibiotic prophylaxis for all patients on immunosuppressants.
    Ribeiro Neto ML; Swigris JJ; Culver DA
    Thorax; 2013 Sep; 68(9):883-4. PubMed ID: 23564341
    [No Abstract]   [Full Text] [Related]  

  • 4. Effect of Co-trimoxazole (Trimethoprim-Sulfamethoxazole) vs Placebo on Death, Lung Transplant, or Hospital Admission in Patients With Moderate and Severe Idiopathic Pulmonary Fibrosis: The EME-TIPAC Randomized Clinical Trial.
    Wilson AM; Clark AB; Cahn T; Chilvers ER; Fraser W; Hammond M; Livermore DM; Maher TM; Parfrey H; Swart AM; Stirling S; Thickett DR; Whyte M;
    JAMA; 2020 Dec; 324(22):2282-2291. PubMed ID: 33289822
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Efficacy and Mechanism Evaluation of Treating Idiopathic Pulmonary fibrosis with the Addition of Co-trimoxazole (EME-TIPAC): study protocol for a randomised controlled trial.
    Hammond M; Clark AB; Cahn AP; Chilvers ER; Fraser WD; Livermore DM; Maher TM; Parfrey H; Swart AM; Stirling S; Thickett D; Whyte M; Wilson A
    Trials; 2018 Feb; 19(1):89. PubMed ID: 29402332
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treating idiopathic pulmonary fibrosis with the addition of co-trimoxazole: a randomised controlled trial.
    Shulgina L; Cahn AP; Chilvers ER; Parfrey H; Clark AB; Wilson EC; Twentyman OP; Davison AG; Curtin JJ; Crawford MB; Wilson AM
    Thorax; 2013 Feb; 68(2):155-62. PubMed ID: 23143842
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treating idiopathic pulmonary fibrosis with the addition of co-trimoxazole: an economic evaluation alongside a randomised controlled trial.
    Wilson EC; Shulgina L; Cahn AP; Chilvers ER; Parfrey H; Clark AB; Twentyman OP; Wilson AM
    Pharmacoeconomics; 2014 Jan; 32(1):87-99. PubMed ID: 24307539
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Are we missing a target group? Expanding the role of co-trimoxazole to the ageing population.
    Lascano J; Stuckelberger A
    Public Health; 2017 Mar; 144():120-121. PubMed ID: 28274372
    [No Abstract]   [Full Text] [Related]  

  • 9. Co-trimoxazole prophylaxis: the debates continue.
    Badri M; Moghraby S
    Lancet HIV; 2015 Apr; 2(4):e118-9. PubMed ID: 26424669
    [No Abstract]   [Full Text] [Related]  

  • 10. Role of co-trimoxazole for urinary tract infections in developing countries.
    Leblebicioglu H; Ozaras R; Sunbul M
    Lancet Infect Dis; 2015 Jul; 15(7):764-5. PubMed ID: 26122444
    [No Abstract]   [Full Text] [Related]  

  • 11. Prophylaxis with co-trimoxazole for HIV infected adults in Africa.
    Anglaret X; Eholie S
    BMJ; 2008 Jul; 337():a304. PubMed ID: 18614521
    [No Abstract]   [Full Text] [Related]  

  • 12. Co-trimoxazole and Wegener's granulomatosis: more than a coincidence?
    Stegeman CA; Tervaert JW; Kallenberg CG
    Nephrol Dial Transplant; 1997 Apr; 12(4):652-5. PubMed ID: 9140987
    [No Abstract]   [Full Text] [Related]  

  • 13. Gonococcal perianal abscess: re-emergence after cessation of co-trimoxazole.
    Read T; Mijch A; Ostergaard L
    Sex Transm Infect; 2002 Oct; 78(5):389. PubMed ID: 12407255
    [No Abstract]   [Full Text] [Related]  

  • 14. Outcome from treatment of Pneumocystis jirovecii pneumonia with co-trimoxazole.
    Fisk M; Sage EK; Edwards SG; Cartledge JD; Miller RF
    Int J STD AIDS; 2009 Sep; 20(9):652-3. PubMed ID: 19710343
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increase in trimethoprim-sulphamethoxazole (co-trimoxazole) resistance at Chris Hani Baragwanath Hospital, Soweto, in the AIDS era.
    Crewe-Brown HH; Reyneke MP; Khoosal M; Becker PJ; Karstaedt AS
    S Afr Med J; 2004 Jun; 94(6):440-2. PubMed ID: 15250455
    [No Abstract]   [Full Text] [Related]  

  • 16. [Hypoglycemic coma and co-trimoxazole in a nondiabetic patient].
    Conan PL; Charton F; Quiblier A; Margery J; Rivière F
    Med Mal Infect; 2016 Jun; 46(4):236-7. PubMed ID: 27039069
    [No Abstract]   [Full Text] [Related]  

  • 17. Level of understanding of co-trimoxazole use among HIV infected, recurrent pulmonary tuberculosis suspects at a national referral tuberculosis clinic in Kampala, Uganda: a qualitative analysis.
    Okwera A; Mafigiri DK; Guwatudde D; Whalen C; Joloba M
    Afr Health Sci; 2015 Mar; 15(1):49-57. PubMed ID: 25834530
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Alopecia areata and relapsing polychondritis or mosaic autoimmunity? The first experience of co-trimoxazole treatment.
    Rozin AP; Schapira D; Bergman R
    Ann Rheum Dis; 2003 Aug; 62(8):778-80. PubMed ID: 12860737
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Trimethoprim-sulfamethoxazole and fulminant ehrlichiosis.
    Brantley RK
    Pediatr Infect Dis J; 2001 Feb; 20(2):231. PubMed ID: 11224854
    [No Abstract]   [Full Text] [Related]  

  • 20. Staphylococcus aureus, trimethoprim-sulfamethoxazole, and Wegener's granulomatosis.
    Kallenberg CG; Stegeman CA; Tervaert JW
    Sarcoidosis Vasc Diffuse Lung Dis; 1996 Oct; 13(3):253-5. PubMed ID: 8946595
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.